Abstract
Purpose
We determined the sperm retrieval rate in men with persistent azoospermia post-chemotherapy in relation to cyclophosphamide equivalent dose (CED), a unit for quantifying alkylating agent exposure.
Methods
Medical records were retrospectively reviewed of 1098 patients diagnosed with non-obstructive azoospermia who had undergone microdissection testicular sperm extraction (mTESE) between January 2010 and 2021 at our institution. Twenty-three patients with a prior history of chemotherapy were included in the study. Oncological data, chemotherapy regime, and dosage were reviewed. The pretreatment hormone profile, CED, and mTESE outcomes were analyzed.
Results
Testicular spermatozoa were successfully retrieved from 11 patients (47%). The mean patient age was 37.3 years (range, 27–41 years), and mean time interval from chemotherapy to mTESE, 11.8 years (range, 1–45 years). Patients exposed to alkylating agents had significantly lower sperm retrieval rates than those not exposed to alkylating agents (1/9, 11% vs. 10/14, 71%, p = 0.009). No men with CED > 4000 mg/m2 (n = 6) had viable sperm in the testes during mTESE. Moreover, patients diagnosed with testicular non-seminomatous germ cell tumors had a favorable sperm retrieval rate (67%) compared to patients with lymphoma (20%) or leukemia (33%).
Conclusion
Patients with permanent azoospermia post-chemotherapy have a lower testicular sperm retrieval rate when the chemotherapy regimen included alkylating agents. In cases where patients have undergone more intensive gonadotoxic treatments, such as higher CED, the likelihood of successful sperm retrieval is low. It is advisable to counsel such patients using the CED model prior to considering surgical sperm retrieval.
Similar content being viewed by others
Data Availability
All relevant data supporting the findings of this study will be made available upon request to qualified researchers for the purpose of replication and further scientific investigation.
References
Bracci L, Schiavoni G, Sistigu A, Belardelli F. Immune-based mechanisms of cytotoxic chemotherapy: implications for the design of novel and rationale-based combined treatments against cancer. Cell Death Differ. 2014;21:15–25. https://doi.org/10.1038/cdd.2013.67.
Green DM, Liu W, Kutteh WH, Ke RW, Shelton KC, Sklar CA, et al. Cumulative alkylating agent exposure and semen parameters in adult survivors of childhood cancer: a report from the St Jude Lifetime Cohort Study. Lancet Oncol. 2014;15:1215–23. https://doi.org/10.1016/S1470-2045(14)70408-5.
Williams DH 4th, Karpman E, Sander JC, Spiess PE, Pisters LL, Lipshultz LI. Pretreatment semen parameters in men with cancer. J Urol. 2009;181:736–40. https://doi.org/10.1016/j.juro.2008.10.023.
Sineath RC, Mehta A. Preservation of fertility in testis cancer management. Urol Clin North Am. 2019;46:341–51. https://doi.org/10.1016/j.ucl.2019.04.010.
Siegel RL, Miller KD, Jemal A. Cancer statistics, 2020. CA Cancer J Clin. 2020;70:7–30. https://doi.org/10.3322/caac.21590.
Miller KD, Fidler-Benaoudia M, Keegan TH, Hipp HS, Jemal A, Siegel RL. Cancer statistics for adolescents and young adults, 2020. CA Cancer J Clin. 2020;70:443–59. https://doi.org/10.3322/caac.21637.
Huang YC, Chen YH. Cancer incidence characteristic evolution based on the National Cancer Registry in Taiwan. J Oncol. 2020;2020:1408793. https://doi.org/10.1155/2020/1408793.
Hung GY, Horng JL, Lee YS, Yen HJ, Chen CC, Lee CY. Cancer incidence patterns among children and adolescents in Taiwan from 1995 to 2009: a population-based study. Cancer. 2014;120:3545–53. https://doi.org/10.1002/cncr.28903.
Hsiao W, Stahl PJ, Osterberg EC, Nejat E, Palermo GD, Rosenwaks Z, et al. Successful treatment of postchemotherapy azoospermia with microsurgical testicular sperm extraction: the Weill Cornell experience. J Clin Oncol. 2011;29:1607–11. https://doi.org/10.1200/JCO.2010.33.7808.
Huang IS, Huang WJ, Wren J, Bennett NE, Brannigan RE. The minimal cyclophosphamide equivalent (MCED) dose as an approach to predict outcome of microdissection testicular sperm extraction in patients with persistent azoospermia after chemotherapy. Fertil Steril. 2018;110:e160. https://doi.org/10.1016/j.fertnstert.2018.07.475.
Corea M, Campagnone J, Sigman M. The diagnosis of azoospermia depends on the force of centrifugation. Fertil Steril. 2005;83:920–2. https://doi.org/10.1016/j.fertnstert.2004.09.028.
Green DM, Nolan VG, Goodman PJ, Whitton JA, Srivastava D, Leisenring WM, et al. The cyclophosphamide equivalent dose as an approach for quantifying alkylating agent exposure: a report from the Childhood Cancer Survivor Study. Pediatr Blood Cancer. 2014;61:53–67. https://doi.org/10.1002/pbc.24679.
Schlegel PN. Testicular sperm extraction: microdissection improves sperm yield with minimal tissue excision. Hum Reprod. 1999;14:131–5. https://doi.org/10.1093/humrep/14.1.131.
Maleki B, Khalili MA, Gholizadeh L, Mangoli E, Agha-Rahimi A. Single sperm vitrification with permeable cryoprotectant-free medium is more effective in patients with severe oligozoospermia and azoospermia. Cryobiology. 2022;104:15–22. https://doi.org/10.1016/j.cryobiol.2021.11.176.
Shin T, Kobayashi T, Shimomura Y, Iwahata T, Suzuki K, Tanaka T, et al. Microdissection testicular sperm extraction in Japanese patients with persistent azoospermia after chemotherapy. Int J Clin Oncol. 2016;21:1167–71. https://doi.org/10.1007/s10147-016-0998-5.
Shiraishi K, Matsuyama H. Microdissection testicular sperm extraction and salvage hormonal treatment in patients with postchemotherapy azoospermia. Urology. 2014;83:100–6. https://doi.org/10.1016/j.urology.2013.08.043.
Chow EJ, Stratton KL, Leisenring WM, Oeffinger KC, Sklar CA, Donaldson SS, et al. Pregnancy after chemotherapy in male and female survivors of childhood cancer treated between 1970 and 1999: a report from the Childhood Cancer Survivor Study cohort. Lancet Oncol. 2016;17:567–76. https://doi.org/10.1016/S1470-2045(16)00086-3.
Howell SJ, Shalet SM. Spermatogenesis after cancer treatment: damage and recovery. J Natl Cancer Inst Monogr. 2005;34:12–7. https://doi.org/10.1093/jncimonographs/lgi003.
Centola GM, Keller JW, Henzler M, Rubin P. Effect of low-dose testicular irradiation on sperm count and fertility in patients with testicular seminoma. J Androl. 1994;15:608–13.
Sandeman TF. The effects of x irradiation on male human fertility. Br J Radiol. 1966;39:901–7. https://doi.org/10.1259/0007-1285-39-468-901.
Meistrich ML. Effects of chemotherapy and radiotherapy on spermatogenesis in humans. Fertil Steril. 2013;100:1180–6. https://doi.org/10.1016/j.fertnstert.2013.08.010.
Acknowledgements
The authors express their gratitude to Howard En-Hao Tien and Irene Yea-Lan Chang for their assistance with statistical analysis and to Li-Jung Chang for her generous technical support.
Funding
This work was supported by the Taipei Veterans General Hospital (VGH 109-C-132 and V112B-034).
Author information
Authors and Affiliations
Contributions
Conceptualization: S-J. Tsai, I-S. Huang. Data curation: S-J. Tsai, I-S. Huang, W-J. Chen, William J. Huang. Formal analysis: all authors.
Funding acquisition: I-Shen Huang, William J. Huang. Investigation: I-S. Huang, L–H. Li, William J. Huang. Title page (with ALL authors’ information). Methodology: I-S. Huang. Project administration: I-S. Huang. Resources: William J. Huang. Software: S-J. Tsai, I-S. Huang. Supervision: I-S. Huang. Validation: I-S. Huang. Visualization: I-S. Huang. Writing—original draft: all authors. Writing—review and editing: all authors.
Corresponding author
Ethics declarations
Ethics approval
The study was performed in accordance with the ethical standards as laid down in the 1964 Declaration of Helsinki and its later amendments. Approval was granted by the Medical Ethics Review Committee (IRB protocol number: 2021–11-001CC).
Competing interests
The authors declare no competing interests.
Additional information
Publisher's note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Tsai, SJ., Li, LH., Chen, WJ. et al. Prediction of microdissection testicular sperm extraction outcomes of azoospermic patients post-chemotherapy using cyclophosphamide equivalent dose. J Assist Reprod Genet 40, 2013–2020 (2023). https://doi.org/10.1007/s10815-023-02870-4
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10815-023-02870-4